Negative symptoms and everyday functioning in schizophrenia: A cross-sectional study in a real world-setting

Psychiatry Research

Volumn 218, Issue 3, 2014, Pages 284-289

  Rocca, Paola ^a,b   Montemagni, Cristiana ^a,b   Zappia, Serena ^a,b   Piterà, Rosellina ^b   Sigaudo, Monica ^a,b   Bogetto, Filippo ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Department of Mental Health ASL TO1 ^*  (Italy)

Author keywords

Avolition; Expressive deficits; Functional milestones; Real world functioning

Indexed keywords

ADULT; AGED; ALOGIA; AMOTIVATION; ANHEDONIA; ANTISOCIAL BEHAVIOR; ARTICLE; BLUNTED AFFECT; CALGARY DEPRESSION SCALE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; HEINRICHS QUALITY OF LIFE SCALE; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEGATIVE SYNDROME; PERSONAL AND SOCIAL PERFORMANCE SCALE; PRIORITY JOURNAL; RATING SCALE; SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOM; SCALE FOR ASSESSMENT OF POSITIVE SYMPTOM; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SOCIAL INTERACTION; ADAPTIVE BEHAVIOR; COGNITION DISORDERS; COMORBIDITY; MIDDLE AGED; PSYCHOLOGY; REGRESSION ANALYSIS; SELF CARE; SOCIAL BEHAVIOR; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CARE; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84902120674     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.04.018     Document Type: Article

References (47)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophrenia Research 1990, 3:247-251.
2. American Psychiatry Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Press, Washington (DC), (text revision (DSM-IV-TR). fourth edition.
3. Andreasen N.C. Negative symptoms in schizophrenia. Definition and Reliability 1982, 39:784-788.
4. Andreasen N.C., Olsen S. Negative vs positive schizophrenia. Definition and validation. Archives of General Psychiatry 1982, 39:789-794.
5. Bell M.D., Corbera S., Johannesen J.K., Fiszdon J.M., Wexler B.E. Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?. Schizophrenia Bulletin 2013, 39:186-196.
6. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 2006, 32:238-245.
7. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?. Schizophrenia Research 2005, 77:151-165.
8. Blanchard J.J., Kring A.M., Horan W.P., Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophrenia Bulletin 2011, 37:291-299.
9. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients[U+05F3] real-world behavior with specific neuropsychological and functional capacity measures. Biological Psychiatry 2008, 63:505-511.
10. Couture S.M., Granholm E.L., Fish S.C. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophrenia Research 2011, 125:152-160.
11. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Disorders (SCID) 1997, American Psychiatric Press, Washington, DC.
12. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam[U+05F3]s razor. Schizophrenia Bulletin 2010, 36:359-369.
13. Gould F., Bowie C.R., Harvey P.D. The influence of demographic factors on functional capacity and everyday functional outcomes in schizophrenia. Journal of Clinical and Experimental Neuropsychology 2012, 34:467-475.
14. Gur R.E., Kohler C.G., Ragland J.D., Siegel S.J., Lesko K., Bilker W.B., Gur R.C. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophrenia Bulletin 2006, 32:279-287.
15. Gur R.E., Loughead J., Kohler C.G., Elliott M.A., Lesko K., Ruparel K., Wolf D.H., Bilker W.B., Gur R.C. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Archives of General Psychiatry 2007, 64:1356-1366.
16. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised 1976, Department of Health:Education and Welfare, Bethesda, US.
17. Harvey P.D. Assessment of everyday functioning in schizophrenia: Implications for treatments aimed at negative symptoms. Schizophrenia Research. 2013, 150(2-3):353-355.
18. Harvey P.D., Heaton R.K., Carpenter W.T., Green M.F., Gold J.M., Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research 2012, 140:1-8.
19. Harvey P.D., Raykov T., Twamley E.W., Vella L., Heaton R.K., Patterson T.L. Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. American Journal of Psychiatry 2011, 168:1195-1201.
20. Harvey P.D., Sabbag S., Prestia D., Durand D., Twamley E.W., Patterson T.L. Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings. Journal of Psychiatry Research 2012, 46:1546-1552.
21. Heinrichs D., Hanlon T., Carpenter W.J. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 1984, 10:388-398.
22. Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research 2011, 132:140-145.
23. Juckel G., Schaub D., Fuchs N., Naumann U., Uhl I., Witthaus H., Hargarter L., Bierhoff H.W., Brüne M. Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophrenia Research 2008, 104:287-293.
24. Keefe R.S., Harvey P.D., Lenzenweger M.F., Davidson M., Apter S.H., Schmeidler J., Mohs R.C., Davis K.L. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Research 1992, 44:153-165.
25. Kelley M.E., van Kammen D.P., Allen D.N. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. American Journal of Psychiatry 1999, 156:406-411.
26. Kimhy D., Yale S., Goetz R.R., McFarr L.M., Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophrenia Bulletin 2006, 32:274-278.
27. Kirkpatrick B., Fischer B. Subdomains within the negative symptoms of schizophrenia: commentary. Schizophrenia Bulletin 2006, 32:246-249.
28. Kirkpatrick B., Strauss G.P., Nguyen L., Fischer B.A., Daniel D.G., Cienfuegos A., Marder S.R. The brief negative symptom scale: psychometric properties. Schizophrenia Bulletin 2011, 37:300-305.
29. Leifker F.R., Bowie C.R., Harvey P.D. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophrenia Research 2009, 115:82-87.
30. Leifker F.R., Patterson T.L., Heaton R.K., Harvey P.D. Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophrenia Bulletin 2011, 37:334-343.
31. Liemburg E., Castelein S., Stewart R., van der Gaag M., Aleman A., Knegtering H. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. Journal of Psychiatry Research 2013, 47:718-725. Genetic Risk and Outcome of Psychosis (GROUP) Investigators.
32. Lipkovich I.A., Deberdt W., Csernansky J.G., Sabbe B., Keefe R.S., Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC Psychiatry 2009, 9:44.
33. Messinger J.W., Trémeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clinical Psychology Review 2011, 31:161-168.
34. Mohamed S., Rosenheck R., Swartz M., Stroup S., Lieberman J.A., Keefe R.S. Relationship of cognition and psychopathology to functional impairment in schizophrenia. American Journal of Psychiatry 2008, 165:978-987.
35. Morosini P., Magliano L., Brambilla L., Ugolini S., Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica 2000, 101:323-329.
36. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. American Journal of Psychiatry 1994, 151:1453-1462.
37. Nakaya M., Ohmori K. A two-factor structure for the Schedule for the Deficit Syndrome in schizophrenia. Psychiatry Research 2008, 158:256-259.
38. Novick D., Haro J.M., Suarez D., Vieta E., Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophrenia Research 2009, 108:223-230.
39. Peralta V., Cuesta M.J. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. American Journal of Psychiatry 1995, 152:1450-1457.
40. Perlick D.A., Rosenheck R.A., Kaczynski R., Bingham S., Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophrenia Research 2008, 99:192-199.
41. Rabinowitz J., Levine S.Z., Garibaldi G., Bugarski-Kirola D., Berardo C.G., Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophrenia Research 2012, 137:147-150.
42. Rocca P., Montemagni C., Castagna F., Giugiario M., Scalese M., Bogetto F. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:373-379.
43. Song Y.Y., Kim K.R., Park J.Y., Lee S.Y., Kang J.I., Lee E., An S.K., Kwon J.S. Associated factors of quality of life in first-episode schizophrenia patients. Psychiatry Investigation 2011, 8:201-206.
44. Strauss G.P., Hong L.E., Gold J.M., Buchanan R.W., McMahon R.P., Keller W.R., Fischer B.A., Catalano L.T., Culbreth A.J., Carpenter W.T., Kirkpatrick B. Factor structure of the Brief Negative Symptom Scale. Schizophrenia Research 2012, 142:96-98.
45. Strauss G.P., Horan W.P., Kirkpatrick B., Fischer B.A., Keller W.R., Miski P., Buchanan R.W., Green M.F., Carpenter W.T. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatry Research 2013, 47:783-790.
46. Swartz M.S., Perkins D.O., Stroup T.S., McEvoy J.P., Nieri J.M., Haak D.C. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophrenia Bulletin 2003, 29:33-43.
47. Ventura J., Hellemann G.S., Thames A.D., Koellner V., Nuechterlein K.H. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophrenia Research 2009, 113:189-199.